Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

7JUJ

Cruzain bound to Gallinamide inhibitor

Summary for 7JUJ
Entry DOI10.2210/pdb7juj/pdb
DescriptorCruzipain, gallinamide A, bound form, POTASSIUM ION, ... (4 entities in total)
Functional Keywordscysteine protease, cruzain, gallinamide, hydrolase, hydrolase-hydrolase inhibitor complex, hydrolase/hydrolase inhibitor
Biological sourceTrypanosoma cruzi
Total number of polymer chains6
Total formula weight140406.87
Authors
Silva, E.B.,Sharma, V.,Alvarez, L.H.,Gerwick, W.H.,McKerrow, J.H.,Podust, L.M. (deposition date: 2020-08-19, release date: 2021-08-25, Last modification date: 2024-10-23)
Primary citationBarbosa Da Silva, E.,Sharma, V.,Hernandez-Alvarez, L.,Tang, A.H.,Stoye, A.,O'Donoghue, A.J.,Gerwick, W.H.,Payne, R.J.,McKerrow, J.H.,Podust, L.M.
Intramolecular Interactions Enhance the Potency of Gallinamide A Analogues against Trypanosoma cruzi .
J.Med.Chem., 65:4255-4269, 2022
Cited by
PubMed Abstract: Gallinamide A, a metabolite of the marine cyanobacterium sp., selectively inhibits cathepsin L-like cysteine proteases. We evaluated the potency of gallinamide A and 23 synthetic analogues against intracellular amastigotes and the cysteine protease, cruzain. We determined the co-crystal structures of cruzain with gallinamide A and two synthetic analogues at ∼2 Å. SAR data revealed that the N-terminal end of gallinamide A is loosely bound and weakly contributes in drug-target interactions. At the C-terminus, the intramolecular π-π stacking interactions between the aromatic substituents at P1' and P1 restrict the bioactive conformation of the inhibitors, thus minimizing the entropic loss associated with target binding. Molecular dynamics simulations showed that in the absence of an aromatic group at P1, the substituent at P1' interacts with tryptophan-184. The P1-P1' interactions had no effect on anti-cruzain activity, whereas anti- potency increased by ∼fivefold, likely due to an increase in solubility/permeability of the analogues.
PubMed: 35188371
DOI: 10.1021/acs.jmedchem.1c02063
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.2 Å)
Structure validation

231564

數據於2025-02-19公開中

PDB statisticsPDBj update infoContact PDBjnumon